In Vitro Activity of a Novel Siderophore-Cephalosporin LCB10-0200 (GT-1), and LCB10-0200/Avibactam, against Carbapenem-Resistant <em>Escherichia coli</em>, <em>Klebsiella pneumoniae</em>, <em>Acinetobacter baumannii</em>, and <em>Pseudomonas aeruginosa</em> Strains at a Tertiary Hospital in Korea
The siderophore–antibiotic conjugate LCB10-0200 (a.k.a. GT-1) has been developed to combat multidrug-resistant Gram-negative bacteria. In this study, the in vitro activity of LCB10-0200 and LCB10-0200/avibactam (AVI) has been investigated against carbapenem-resistant <i>Escherichia coli</i&...
Main Authors: | Le Phuong Nguyen, Chul Soon Park, Naina Adren Pinto, Hyunsook Lee, Hyun Soo Seo, Thao Nguyen Vu, Hung Mai, An H. T. Pham, Eris Jang, Young Lag Cho, Karrie Goglin, Kevin Nguyen, Richard White, Roshan D’Souza, Derrick E. Fouts, Dongeun Yong |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/4/370 |
Similar Items
-
Antibacterial Activity of LCB10-0200 against <i>Klebsiella pneumoniae</i>
by: Sang-Hun Oh, et al.
Published: (2021-09-01) -
In Vivo Activity of LCB 01-0699, a Prodrug of LCB 01-0648, against Staphylococcus aureus
by: Sang-Hun Oh, et al.
Published: (2017-11-01) -
In Vitro Activities of LCB 01-0648, a Novel Oxazolidinone, against Gram-Positive Bacteria
by: Sang-Hun Oh, et al.
Published: (2017-03-01) -
Studies on the Crystal Growth and Characterization of Large Size Sr:LCB Single Crystals
by: Xuliang Zhang, et al.
Published: (2022-03-01) -
Susceptibility and Resistance of SARS-CoV-2 Variants to LCB1 and Its Multivalent Derivatives
by: Hongliang Jin, et al.
Published: (2023-12-01)